Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesia.
Rapaport
A
A
Department of Neurology, Wolfson Medical Center, Holon, Israel.
Sadeh
M
M
Stein
D
D
Levine
J
J
Sirota
P
P
Mosheva
T
T
Stir
S
S
Elitzur
A
A
Reznik
I
I
Geva
D
D
Rabey
J M
JM
D000368:Aged; D000369:Aged, 80 and over; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage* / Q000009:adverse effects; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D005152:Facial Muscles / Q000187:drug effects; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D019274:Botulinum Toxins, Type A